Skip to main content

Table 2 Correlation between TET1 expression level and clinic-pathological parameters

From: TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells

Clinical-pathologic parameters

TET1 expression

p value

Low (N = 32)

High (N = 31)

 

Age (years)

≥60

24

18

P = 0.154

<60

8

13

Gender

male

18

18

P = 0.884

female

14

13

Tumor size (cm)

≥5 cm

10

8

P = 0.663

<5 cm

22

23

pathological grading

I,II

17

17

P = 0.891

III,IV

15

14

Nerve metastasis

Yes

14

13

P = 0.884

No

18

18

Lymph node metastasis

Yes

12

13

P = 0.719

No

20

18

Distant metastasis

Yes

2

2

P = 0.974

No

30

31

TNM stage*

IA,IB,IIA

20

17

P = 0.537

IIB,III,IV

12

14

  1. *TNM stage was classified according to the AJCC Staging Manual (7th Edition)